|Application ||WB, E|
|Other Accession||106759(mouse), 363328(rat), NP_891549.1|
|Predicted||Human, Mouse, Rat, Pig, Cow, Dog|
|Calculated MW||76422 Da|
|Other Names||TICAM1; toll-like receptor adaptor molecule 1; PRVTIRB; TICAM-1; TRIF; TIR domain containing adaptor inducing interferon-beta; TIR domain-containing adapter molecule 1; TIR domain-containing adapter protein inducing IFN-beta; proline-rich, vinculin and TIR domain-containing protein B; putative NF-kappa-B-activating protein 502H; toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta|
|Format||Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.|
|Immunogen||Peptide with sequence PDGATFCEDFQVP, from the internal region of the protein sequence according to NP_891549.1.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||Goat Anti-TICAM-1 / TRIF Antibody (internal region) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Involved in innate immunity against invading pathogens. Adapter used by TLR3 and TLR4 (through TICAM2) to mediate NF- kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis. Ligand binding to these receptors results in TRIF recruitment through its TIR domain. Distinct protein- interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively.|
|Cellular Location||Cytoplasmic vesicle, autophagosome. Note=Colocalizes with UBQLN1 in the autophagosome.|
|Tissue Location||Ubiquitously expressed but with higher levels in liver.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist. Bowen WS, Minns LA, Johnson DA, Mitchell TC, Hutton MM, Evans JT. Science signaling 2012 Feb 5 (211): ra13.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.